State Treasurer State of Michigan Has $39.49 Million Holdings in Illumina, Inc. (ILMN)

State Treasurer State of Michigan reduced its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 22.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 198,260 shares of the life sciences company’s stock after selling 58,700 shares during the quarter. State Treasurer State of Michigan owned 0.14% of Illumina worth $39,493,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Advisory Services Network LLC raised its position in Illumina by 13.0% during the second quarter. Advisory Services Network LLC now owns 772 shares of the life sciences company’s stock worth $134,000 after acquiring an additional 89 shares in the last quarter. Penserra Capital Management LLC raised its position in Illumina by 13.0% during the second quarter. Penserra Capital Management LLC now owns 884 shares of the life sciences company’s stock worth $153,000 after acquiring an additional 102 shares in the last quarter. Paradigm Asset Management Co. LLC raised its position in Illumina by 5.6% during the second quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock worth $165,000 after acquiring an additional 50 shares in the last quarter. Patten Group Inc. raised its position in Illumina by 2.7% during the first quarter. Patten Group Inc. now owns 965 shares of the life sciences company’s stock worth $166,000 after acquiring an additional 25 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. raised its position in Illumina by 11.3% during the second quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock worth $171,000 after acquiring an additional 100 shares in the last quarter. 93.32% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts have issued reports on ILMN shares. Deutsche Bank AG set a $175.00 price target on shares of Illumina and gave the stock a “hold” rating in a research report on Friday, July 28th. Canaccord Genuity raised shares of Illumina from a “hold” rating to a “buy” rating and upped their price target for the stock from $170.00 to $215.00 in a research report on Monday, August 7th. Morgan Stanley reaffirmed an “underweight” rating and set a $122.00 price target (up from $115.00) on shares of Illumina in a research report on Monday, July 10th. Barclays PLC reaffirmed a “hold” rating and set a $150.00 price target on shares of Illumina in a research report on Wednesday, July 19th. Finally, Vetr lowered shares of Illumina from a “strong-buy” rating to a “hold” rating and set a $202.18 price target on the stock. in a research report on Wednesday, August 2nd. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $189.71.

COPYRIGHT VIOLATION WARNING: “State Treasurer State of Michigan Has $39.49 Million Holdings in Illumina, Inc. (ILMN)” was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.themarketsdaily.com/2017/10/23/state-treasurer-state-of-michigan-has-39-49-million-holdings-in-illumina-inc-ilmn.html.

Illumina, Inc. (ILMN) traded up 1.31% during trading on Monday, reaching $212.62. 569,663 shares of the company’s stock were exchanged. Illumina, Inc. has a 12 month low of $119.37 and a 12 month high of $214.50. The firm has a 50 day moving average of $205.74 and a 200-day moving average of $186.97. The stock has a market cap of $31.04 billion, a PE ratio of 42.66 and a beta of 0.76.

Illumina (NASDAQ:ILMN) last released its earnings results on Tuesday, August 1st. The life sciences company reported $0.82 EPS for the quarter, topping analysts’ consensus estimates of $0.68 by $0.14. Illumina had a return on equity of 19.69% and a net margin of 30.27%. The firm had revenue of $662.00 million for the quarter, compared to analysts’ expectations of $642.38 million. During the same period in the prior year, the firm posted $0.86 earnings per share. The company’s quarterly revenue was up 10.3% on a year-over-year basis. On average, equities research analysts anticipate that Illumina, Inc. will post $3.65 earnings per share for the current fiscal year.

In other news, SVP Oene Mark Van sold 1,250 shares of the stock in a transaction on Thursday, October 12th. The stock was sold at an average price of $207.21, for a total value of $259,012.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jay T. Flatley sold 20,000 shares of the stock in a transaction on Tuesday, October 10th. The stock was sold at an average price of $203.27, for a total value of $4,065,400.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 182,766 shares of company stock worth $36,411,334. Insiders own 1.60% of the company’s stock.

Illumina Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply